🇺🇸 FDA
Patent

US 11083708

Pharmacological restoration of epithelial or endothelial barrier integrity by agents blocking EPAC/RAP1 signaling

granted A61KA61K31/277A61K31/4196

Quick answer

US patent 11083708 (Pharmacological restoration of epithelial or endothelial barrier integrity by agents blocking EPAC/RAP1 signaling) held by The Regents of the University of California expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/277, A61K31/4196, A61K31/42, A61K9/0019